Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has announcements × pembrolizumab × CNS × Clear all

Sponsor

Cancer Type

Gastrointestinal 9 Thoracic 8 Genitourinary 7 Gynecologic 6 Dermatologic 5 Head & Neck 3 Other solid neoplasm 2 Breast 2 Tumor-Agnostic 1 Sarcoma 1 NET 1 Lymphoid 1 Endocrine 1

Interventions

TIC10 compound 4 trametinib 2 selpercatinib 2 naxitamab 2 entrectinib 2 dabrafenib 2 Granulocyte-Macrophage Colony-Stimulating Factor 2 Crizotinib 2 AZD 6244 2 vorasidenib 1 tucatinib 1 tovorafenib 1 sacituzumab govitecan 1 mirdametinib 1 lutetium Lu 177 dotatate 1 copper dotatate CU-64 1 belzutifan 1 Vincristine 1 Trastuzumab 1 Lutetium-177 1 Lutetium 1 Eflornithine 1 Carboplatin 1 Capecitabine 1 3-Iodobenzylguanidine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡